RankingsPricing
  1. JP-listed companies
  2. Nxera Pharma Co., Ltd.
  3. Financials
  4. Revenue

Nxera Pharma Co., Ltd.【JP:4565】

Market cap
¥78.2B
P/E ratio
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Dec 31, 202428,835+125.87%
Dec 31, 202312,766-18.00%
Dec 31, 202215,569-12.10%
Dec 31, 202117,712+100.32%
Dec 31, 20208,842-9.09%
Dec 31, 20199,726+238.65%
Dec 31, 20182,872-58.71%
Mar 31, 20186,955-63.20%
Mar 31, 201718,901+131.89%
Mar 31, 20168,151+122.04%
Mar 31, 20153,671+77.43%
Mar 31, 20142,069+5.67%
Mar 31, 20131,958+127.15%
Mar 31, 2012862

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)